HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

P6 acupoint stimulation for prevention of postoperative nausea and vomiting in patients undergoing craniotomy: study protocol for a randomized controlled trial.

AbstractBACKGROUND:
The incidence of postoperative nausea and vomiting (PONV) is 50 to 79% after neurosurgery. Our study is designed to evaluate the efficacy of pericardium 6 (P6; also known as Neiguan) acupoint stimulation versus placebo, and versus routine antiemetic for the prevention of PONV after craniotomy, as well as to compare the efficacy of invasive acupuncture with non-invasive transcutaneous electrical nerve stimulation (TENS) on P6.
METHODS/DESIGN:
This is a single-center, prospective, double-blind, five-arm, parallel-group, randomized controlled trial (RCT). All groups will be given routine intravenous ondansetron 8 mg administered before skin closure. Upon regaining consciousness from general anaesthesia, patients will receive one of five interventions: 1) P6 acupuncture bilaterally for 30 minutes, stimulated every 10 minutes to keep de qi sensation; 2) sham acupuncture bilaterally for 30 minutes with no stimulation; 3) P6 stimulation via active TENS electrodes bilaterally for 30 minutes, with stimulation frequency and intensity set to when de qi sensation is felt; 4) sham P6 stimulation via inactive TENS electrode bilaterally for 30 minutes; and 5) usual practice of pharmacological emesis prevention. The incidence of postoperative vomiting during the first 24 hours is the main outcome. Secondary outcomes include: complete response rate, severity of nausea, total rescue metoclopramide dose used and patient satisfaction with PONV management.
DISCUSSION:
The results from this study could potentially confirm that P6 acupoint stimulation is an effective adjunct to standard antiemetic drug therapy for the prevention of PONV in patients undergoing craniotomy. Our study may also confirm that conventional acupuncture is more effective than TENS.
TRIAL REGISTRATION:
This study is registered with the Chinese Clinical Trial Registry: ChiCTR-TRC-13003026.
AuthorsJian-qin Lv, Rui-zhi Feng, Ning Li
JournalTrials (Trials) Vol. 14 Pg. 153 ( 2013) ISSN: 1745-6215 [Electronic] England
PMID23710881 (Publication Type: Comparative Study, Journal Article, Randomized Controlled Trial)
Chemical References
  • Antiemetics
  • Ondansetron
  • Metoclopramide
Topics
  • Acupuncture Points
  • Acupuncture Therapy (methods)
  • Administration, Intravenous
  • Antiemetics (administration & dosage)
  • China
  • Clinical Protocols
  • Combined Modality Therapy
  • Craniotomy (adverse effects)
  • Double-Blind Method
  • Humans
  • Metoclopramide (administration & dosage)
  • Ondansetron (administration & dosage)
  • Patient Satisfaction
  • Postoperative Nausea and Vomiting (etiology, prevention & control)
  • Prospective Studies
  • Research Design
  • Severity of Illness Index
  • Time Factors
  • Transcutaneous Electric Nerve Stimulation
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password: